H-1B sponsorship profile: AVEO Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, AVEO Pharmaceuticals, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on AVEO Pharmaceuticals, Inc’s H-1B petitions range from $130,000 at the low end to $160,000 at the high end, with a petition-weighted average of $140,000. That range reflects the mix of occupations the company sponsors, led by Senior Analyst, Commercial Analytics (2 petitions at $130,000 avg), followed by PV Specialist, Compliance and Alliance Manager. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. AVEO Pharmaceuticals, Inc is headquartered in Boston, MA under NAICS code 5417, and places H-1B workers across 2 states, most heavily in PA, MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where AVEO Pharmaceuticals, Inc ranks. By H-1B petition volume, AVEO Pharmaceuticals, Inc is #37,433 of 119,880 employers nationally and #1,704 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.